[go: up one dir, main page]

RU2008139905A - Фармацевтическая композиция для наружного применения - Google Patents

Фармацевтическая композиция для наружного применения Download PDF

Info

Publication number
RU2008139905A
RU2008139905A RU2008139905/15A RU2008139905A RU2008139905A RU 2008139905 A RU2008139905 A RU 2008139905A RU 2008139905/15 A RU2008139905/15 A RU 2008139905/15A RU 2008139905 A RU2008139905 A RU 2008139905A RU 2008139905 A RU2008139905 A RU 2008139905A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
external use
onychomycosis
crotamiton
pyrrolidone
Prior art date
Application number
RU2008139905/15A
Other languages
English (en)
Other versions
RU2423128C2 (ru
Inventor
Хироказу КОБАЯСИ (JP)
Хироказу Кобаяси
Акира НОЗАВА (JP)
Акира Нозава
Катсумаса АРИЙОСИ (JP)
Катсумаса Арийоси
Original Assignee
Нихон Нохияку Ко.,Лтд. (Jp)
Нихон Нохияку Ко.,Лтд.
Пола Фарма Инк. (Jp)
Пола Фарма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нихон Нохияку Ко.,Лтд. (Jp), Нихон Нохияку Ко.,Лтд., Пола Фарма Инк. (Jp), Пола Фарма Инк. filed Critical Нихон Нохияку Ко.,Лтд. (Jp)
Publication of RU2008139905A publication Critical patent/RU2008139905A/ru
Application granted granted Critical
Publication of RU2423128C2 publication Critical patent/RU2423128C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Фармацевтическая композиция для наружного применения, содержащая: ! i) люликоназол, представленный следующей структурной формулой (1) и/или его соль; ! ! и ii) одно, два или более веществ, выбранных из N-метил-2-пирролидона, пропилен карбоната и кротамитона. ! 2. Фармацевтическая композиция для наружного применения по п.1, предназначенная для лечения или предупреждения онихомикоза.

Claims (2)

1. Фармацевтическая композиция для наружного применения, содержащая:
i) люликоназол, представленный следующей структурной формулой (1) и/или его соль;
Figure 00000001
и ii) одно, два или более веществ, выбранных из N-метил-2-пирролидона, пропилен карбоната и кротамитона.
2. Фармацевтическая композиция для наружного применения по п.1, предназначенная для лечения или предупреждения онихомикоза.
RU2008139905/15A 2006-03-08 2006-10-02 Фармацевтическая композиция для наружного применения RU2423128C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006062079 2006-03-08
JP2006-062079 2006-03-08
JP2006215871 2006-08-08
JP2006-215871 2006-08-08

Publications (2)

Publication Number Publication Date
RU2008139905A true RU2008139905A (ru) 2010-04-20
RU2423128C2 RU2423128C2 (ru) 2011-07-10

Family

ID=38474687

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008139905/15A RU2423128C2 (ru) 2006-03-08 2006-10-02 Фармацевтическая композиция для наружного применения

Country Status (16)

Country Link
US (3) US8349882B2 (ru)
EP (1) EP2005958B1 (ru)
JP (1) JP5160409B2 (ru)
KR (1) KR101343291B1 (ru)
AU (1) AU2006339842B2 (ru)
BR (1) BRPI0621446C1 (ru)
CA (1) CA2645070C (ru)
ES (1) ES2421613T3 (ru)
IL (1) IL193894A (ru)
MX (1) MX2008011435A (ru)
NZ (1) NZ571819A (ru)
PL (1) PL2005958T3 (ru)
RU (1) RU2423128C2 (ru)
TW (1) TWI389686B (ru)
WO (1) WO2007102242A1 (ru)
ZA (1) ZA200808531B (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5184341B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
EP2005958B1 (en) 2006-03-08 2013-04-17 Nihon Nohyaku Co., Ltd. External pharmaceutical composition
WO2007102243A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
EP2191827B1 (en) * 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
US20100204293A1 (en) 2007-09-05 2010-08-12 Pola Pharma Inc. Pharmaceutical composition
ES2591030T3 (es) * 2007-09-05 2016-11-24 Pola Pharma Inc. Composición farmacéutica antifúngica
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
JP5688405B2 (ja) * 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102481286B (zh) * 2009-08-25 2014-02-26 宝丽制药股份有限公司 抗真菌药物组合物
JP5832451B2 (ja) * 2010-06-11 2015-12-16 株式会社ポーラファルマ 抗真菌医薬組成物
JP5980700B2 (ja) * 2012-03-19 2016-08-31 株式会社ポーラファルマ 抗真菌医薬組成物が充填された樹脂容器
WO2014041846A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
RU2621615C2 (ru) 2012-09-14 2017-06-06 Пола Фарма Инк. Фармацевтическая композиция, содержащая луликоназол
EP2895165B1 (en) 2012-09-14 2016-12-14 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
US9199977B2 (en) 2012-09-14 2015-12-01 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
JP5460797B1 (ja) * 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
JP5662495B2 (ja) * 2013-02-08 2015-01-28 株式会社ポーラファルマ 可溶化剤形の医薬組成物
JP5730340B2 (ja) * 2013-02-08 2015-06-10 株式会社ポーラファルマ 貯留型医薬組成物
JP6067399B2 (ja) * 2013-02-08 2017-01-25 株式会社ポーラファルマ 医薬組成物
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP6503626B2 (ja) * 2013-03-28 2019-04-24 大正製薬株式会社 医薬組成物
JP6503627B2 (ja) * 2013-03-28 2019-04-24 大正製薬株式会社 医薬液体組成物
WO2014185542A1 (en) * 2013-05-17 2014-11-20 Pola Pharma Inc. Pharmaceutical composition for treating vaginitis or pneumonia
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
US9480746B2 (en) 2014-04-21 2016-11-01 Pola Pharma Inc. Resin container filled with antifungal pharmaceutical composition
JP6110839B2 (ja) * 2014-12-04 2017-04-05 株式会社ポーラファルマ 可溶化剤形の医薬組成物
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
CN112773762B (zh) * 2019-11-08 2023-04-18 威智医药股份有限公司 外用药物组合物及其制备方法和应用
RU2738595C1 (ru) * 2020-03-17 2020-12-14 Марина Михайловна Бурмина Лечебно-косметическая композиция

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267169A (en) 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
JPS5815909A (ja) 1981-07-22 1983-01-29 Toko Yakuhin Kogyo Kk 抗真菌外用剤
US4636520A (en) 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound
JPH0236572B2 (ja) 1984-11-13 1990-08-17 Hokuriku Pharmaceutical Suteroidoo177monoesuteruganjukuriimuzai
JPS6293227A (ja) * 1985-10-19 1987-04-28 Nippon Nohyaku Co Ltd 抗真菌剤
US4764381A (en) 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
JPH0774144B2 (ja) 1986-03-12 1995-08-09 久光製薬株式会社 尿素を含有する皮膚用組成物
US5686489A (en) 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
JPH01242525A (ja) 1988-03-25 1989-09-27 Nippon Nohyaku Co Ltd 抗真菌外用剤
JPH01246219A (ja) 1988-03-25 1989-10-02 Nippon Nohyaku Co Ltd 抗真菌外用クリーム組成物
JP3030780B2 (ja) 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH02264723A (ja) 1989-04-06 1990-10-29 Taisho Pharmaceut Co Ltd 抗真菌剤
NZ233827A (en) 1989-05-26 1991-06-25 Abbott Lab Pharmaceutical composition comprising clarithromycin, triglyceride oil and stabilising agent
IL97012A0 (en) 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
US5340836A (en) 1991-02-19 1994-08-23 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
JP2555555B2 (ja) 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
JPH06199701A (ja) 1992-12-29 1994-07-19 Lion Corp 外用消炎鎮痛剤
JPH06211651A (ja) 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc 爪白癬治療用組成物
JPH0774144A (ja) 1993-06-29 1995-03-17 Sony Corp プラズマ装置のクリーニング方法
ES2160631T5 (es) 1993-07-01 2005-07-16 Yamanouchi Europe B.V. Utilizacion de agentes tensioactivos no ionicos en composiciones estables de retinoides para aplicacion topica.
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
JP2860748B2 (ja) 1993-12-24 1999-02-24 エスエス製薬株式会社 安定な酪酸ヒドロコルチゾン含有クリーム剤
JP3803393B2 (ja) 1994-01-12 2006-08-02 久光製薬株式会社 爪白癬治療用組成物
JP3629283B2 (ja) 1994-02-15 2005-03-16 ポーラ化成工業株式会社 皮膚外用剤
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
GB9420355D0 (en) 1994-10-10 1994-11-23 Univ Nottingham Preparation of protein microspheres, films and coatings
AU3673195A (en) 1994-10-13 1996-05-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for nail ringworm
SE9502244D0 (sv) 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
ZA965745B (en) 1995-07-08 1997-01-27 Nihon Hohyaku Co Ltd Antifungal agent compound therefor process for producing the same and method for using the same
EP0858803A4 (en) 1995-08-28 2000-02-09 Showa Pharm Chem Ind COMPOSITION FOR LOCAL ANESTHESIA
US5993787A (en) 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
JP4253047B2 (ja) 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
JP4227677B2 (ja) 1996-12-10 2009-02-18 杏林製薬株式会社 被膜形成性抗真菌剤組成物
JPH10226686A (ja) 1996-12-10 1998-08-25 Nippon Nohyaku Co Ltd 光学活性体である（ｒ）−（ｅ）−（４−置換フェニル−１，３−ジチオラン−２−イリデン）−１−イミダゾールアセトニトリル誘導体及び抗真菌剤及びそれらの製造方法
WO2000001384A1 (fr) * 1998-07-01 2000-01-13 Lead Chemical Co., Ltd. Preparation a base de ketotifene destinee a etre absorbee par voie percutanee
US5962536A (en) 1998-07-31 1999-10-05 Komer; Gene Injectable propofol formulations
US6740326B1 (en) 1998-09-10 2004-05-25 Bioequal Ag Topical nail care compositions
US20040208906A1 (en) 1999-07-12 2004-10-21 Daiichi Suntory Pharma Co., Ltd. Pharmaceutical composition for topical administration
JP2001064206A (ja) 1999-08-30 2001-03-13 Isp Japan Kk 経皮吸収促進組成物
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6428654B1 (en) 2000-04-05 2002-08-06 Hercules Incorporated Fungicidal method
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
JP2002193755A (ja) 2000-12-28 2002-07-10 Sansho Seiyaku Co Ltd フケ・カユミ防止頭髪用および洗髪用化粧料
JP2002284702A (ja) 2001-01-19 2002-10-03 Teika Seiyaku Kk 外用抗真菌製剤
KR100423666B1 (ko) 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
US6585963B1 (en) 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US20030017207A1 (en) 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
JP2002363070A (ja) 2001-06-06 2002-12-18 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
BR0212311A (pt) 2001-09-04 2004-10-13 Trommsdorff Arzneimittel Emplastro para o tratamento de disfunções e distúrbios de unhas
JP2003252798A (ja) 2002-02-28 2003-09-10 Shiseido Co Ltd 抗菌ゲル製剤
AU2003242238A1 (en) 2002-06-18 2003-12-31 Pola Chemical Industries Inc. Antifungal medicinal compositions
US6846837B2 (en) 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
JP4387639B2 (ja) 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
ES2301814T3 (es) 2002-09-05 2008-07-01 Galderma S.A. Solucion para aplicacion ungueal.
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
DE602004021253D1 (de) 2003-03-21 2009-07-09 Nexmed Holdings Inc Antimykotischer nagellack und anwendungsverfahren
WO2004091521A2 (en) 2003-04-10 2004-10-28 Neurogesx, Inc. Methods and compositions for administration of trpv1 agonists
WO2005000287A1 (ja) 2003-06-25 2005-01-06 Hisamitsu Pharmaceutical Co., Inc. 水虫治療用外用剤
JP4431369B2 (ja) 2003-11-21 2010-03-10 久光製薬株式会社 抗真菌エアゾール外用製剤
JP4429035B2 (ja) 2004-02-27 2010-03-10 久光製薬株式会社 角質貯留性を高めた外用クリーム製剤
JP3783104B2 (ja) * 2004-03-31 2006-06-07 小林製薬株式会社 抗真菌性外用組成物
EP1767218B1 (en) 2004-06-15 2016-08-10 Hisamitsu Pharmaceutical Co., Inc. Antiinflammatory and analgesic preparation for external use
JP4690672B2 (ja) 2004-07-20 2011-06-01 岩城製薬株式会社 乳剤性皮膚外用剤
JP3800232B2 (ja) 2004-09-30 2006-07-26 小林製薬株式会社 抗真菌性外用組成物
JP2006306734A (ja) 2005-04-26 2006-11-09 Tsumura & Co 尿素配合外用剤
JP5290582B2 (ja) 2005-12-28 2013-09-18 帝國製薬株式会社 爪用医薬組成物
EP2005958B1 (en) 2006-03-08 2013-04-17 Nihon Nohyaku Co., Ltd. External pharmaceutical composition
JP5184341B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
WO2007102243A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20100204293A1 (en) 2007-09-05 2010-08-12 Pola Pharma Inc. Pharmaceutical composition
ES2591030T3 (es) 2007-09-05 2016-11-24 Pola Pharma Inc. Composición farmacéutica antifúngica
EP2191827B1 (en) 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
CN102395274B (zh) 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5688405B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物

Also Published As

Publication number Publication date
BRPI0621446A2 (pt) 2011-12-13
JP5160409B2 (ja) 2013-03-13
ES2421613T3 (es) 2013-09-04
EP2005958A1 (en) 2008-12-24
KR20080111044A (ko) 2008-12-22
TW200744588A (en) 2007-12-16
AU2006339842B2 (en) 2012-06-07
PL2005958T3 (pl) 2013-11-29
NZ571819A (en) 2011-04-29
IL193894A (en) 2015-03-31
RU2423128C2 (ru) 2011-07-10
BRPI0621446B8 (pt) 2021-02-02
IL193894A0 (en) 2009-09-22
ZA200808531B (en) 2009-12-30
MX2008011435A (es) 2009-02-03
WO2007102242A1 (ja) 2007-09-13
US20130096187A1 (en) 2013-04-18
EP2005958B1 (en) 2013-04-17
US20170071911A1 (en) 2017-03-16
KR101343291B1 (ko) 2013-12-18
US20090137651A1 (en) 2009-05-28
JPWO2007102242A1 (ja) 2009-07-23
AU2006339842A1 (en) 2007-09-13
BRPI0621446B1 (pt) 2020-10-13
BRPI0621446C1 (pt) 2021-05-25
US8349882B2 (en) 2013-01-08
CA2645070C (en) 2014-02-04
CA2645070A1 (en) 2007-09-13
EP2005958A4 (en) 2010-09-15
TWI389686B (zh) 2013-03-21

Similar Documents

Publication Publication Date Title
RU2008139905A (ru) Фармацевтическая композиция для наружного применения
EA202092003A1 (ru) Соединения для лечения болезни гентингтона
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
EA201000050A1 (ru) Замещенные бициклолактамные соединения
EA200700489A1 (ru) Новые бензоконденсированные гетероарилсульфамидные производные, полезные в качестве противоконвульсивных средств
EA200801997A1 (ru) Новые соединения
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
EA201070786A1 (ru) Бензофуропиримидиноны
EA200970156A1 (ru) Пиридизиноновые производные
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
EA200802209A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
CY1110900T1 (el) Χημικες ενωσεις
CY1108275T1 (el) Χημικες ενωσεις
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA200702498A1 (ru) N-(пиридин-2-ил)сульфонамидные производные
MY151295A (en) Pyrimidyl indoline compound
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA201071329A1 (ru) Диамидные производные адамантана и их применение
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
CY1115247T1 (el) Ενωσεις συμπυκνωμενων δακτυλιων και χρηση αυτων
EA200970124A1 (ru) Производные 2-арилиндола в качестве ингибиторов npges-1
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
EA201290229A1 (ru) Производные спиролактама и их применение
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства